Spruce Biosciences Inc.

NASDAQ: SPRB · Real-Time Price · USD
8.75
-0.55 (-5.93%)
At close: Jun 09, 2025, 3:57 PM
8.75
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT

Spruce Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-53.04M -47.92M -46.18M -42.29M
Depreciation & Amortization
46K 70K 74K 68K
Stock-Based Compensation
5.35M 4.62M 3.63M 3.96M
Other Working Capital
-6.53M 8.45M 2.53M 806K
Other Non-Cash Items
n/a -404K -340K 313K
Deferred Income Tax
n/a n/a n/a 121K
Change in Working Capital
-8.57M 10.36M 1.13M 1.96M
Operating Cash Flow
-55.96M -33.27M -41.68M -35.88M
Capital Expenditures
n/a -7K -8K -93K
Cash Acquisitions
n/a n/a -23.7M n/a
Purchase of Investments
n/a -11.88M -36.8M -79.08M
Sales Maturities Of Investments
n/a 67.67M 60.5M 121K
Other Investing Acitivies
n/a n/a 23.7M -121K
Investing Cash Flow
n/a 55.78M 23.69M -79.17M
Debt Repayment
n/a -1.62M n/a 220K
Common Stock Repurchased
66K n/a -40K 134K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-1.62M -2.85M -201K 423K
Financial Cash Flow
-1.62M 49.14M -241K 643K
Net Cash Flow
-57.59M 71.64M -18.23M -114.4M
Free Cash Flow
-55.96M -33.28M -41.69M -35.97M